Literature DB >> 31409918

Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling.

Daisuke Aono1, Mitsuhiro Kometani1, Shigehiro Karashima1, Mikiya Usukura2, Yuko Gondo1, Atsushi Hashimoto1, Masashi Demura3, Kenji Furukawa4, Yoshiyu Takeda1, Masaaki Kawashiri1, Takashi Yoneda5,6,7.   

Abstract

The primary aldosteronism (PA) subtype is usually confirmed by CT and adrenal venous sampling (AVS). However, the subtype diagnosis by AVS is not necessarily consistent with the subtype diagnosis by CT. Patients with PA who show bilateral lesions (normal-appearing adrenals or bilateral adrenal nodules) on CT but unilateral disease on AVS are often found. The aim of this study was to evaluate whether patients with PA subtype discordance between CT and AVS obtain benefits from unilateral adrenalectomy. We retrospectively analyzed 362 consecutive patients with PA who underwent both CT and adrenocorticotropic hormone-unstimulated AVS at Kanazawa University Hospital. Surgical outcomes for unilateral PA were evaluated according to the criteria of the Primary Aldosteronism Surgical Outcome study. In our study, the success rate of AVS in patients with bilateral lesions on CT was 89% (191/214). Furthermore, the discordance rate between CT and AVS in patients with bilateral lesions on CT was 39% (74/191). After surgery, patients with bilateral lesions on CT but unilateral disease on AVS (n = 17) had a lower complete biochemical success rate than those with unilateral lesions on CT and ipsilateral disease on AVS (n = 30) (41% vs. 80%, p = 0.01), but clinical and biochemical benefits (the complete and partial success combined) were not significantly different between them (76% vs. 93% (p = 0.11) and 70% vs. 90% (p = 0.10), respectively). In conclusion, patients with bilateral lesions on CT but unilateral disease on AVS benefited from surgery, and AVS should be performed for patients who pursue surgical management when the CT findings suggest bilateral lesions.

Entities:  

Keywords:  adrenal vein sampling; computed tomography; primary aldosteronism

Mesh:

Substances:

Year:  2019        PMID: 31409918     DOI: 10.1038/s41440-019-0310-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  1 in total

1.  Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.

Authors:  Yuto Yamazaki; Yasuhiro Nakamura; Kei Omata; Kazue Ise; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yukinaga Nozawa; Celso E Gomez-Sanchez; Scott A Tomlins; William E Rainey; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

  1 in total
  7 in total

1.  Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register).

Authors:  Marta Araujo-Castro; Miguel Paja Fano; Marga González Boillos; Begoña Pla Peris; Eider Pascual-Corrales; Ana María García Cano; Paola Parra Ramírez; Patricia Martín Rojas-Marcos; Jorge Gabriel Ruiz-Sanchez; Almudena Vicente Delgado; Emilia Gómez Hoyos; Rui Ferreira; Iñigo García Sanz; Mònica Recasens Sala; Rebeca Barahona San Millan; María José Picón César; Patricia Díaz Guardiola; Juan Jesús García González; Carolina M Perdomo; Laura Manjón Miguélez; Rogelio García Centeno; Juan Carlos Percovich; Ángel Rebollo Román; Paola Gracia Gimeno; Cristina Robles Lázaro; Manuel Morales-Ruiz; Felicia A Hanzu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

Review 2.  The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.

Authors:  Gian Paolo Rossi; Valeria Bisogni; Alessandra Violet Bacca; Anna Belfiore; Maurizio Cesari; Antonio Concistrè; Rita Del Pinto; Bruno Fabris; Francesco Fallo; Cristiano Fava; Claudio Ferri; Gilberta Giacchetti; Guido Grassi; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Giuseppe Maiolino; Dario Manfellotto; Pietro Minuz; Silvia Monticone; Alberto Morganti; Maria Lorenza Muiesan; Paolo Mulatero; Aurelio Negro; Gianfranco Parati; Martino F Pengo; Luigi Petramala; Francesca Pizzolo; Damiano Rizzoni; Giacomo Rossitto; Franco Veglio; Teresa Maria Seccia
Journal:  Int J Cardiol Hypertens       Date:  2020-04-15

3.  Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis.

Authors:  Yaqiong Zhou; Dan Wang; Licheng Jiang; Fei Ran; Sichao Chen; Peng Zhou; Peijian Wang
Journal:  BMJ Open       Date:  2020-12-31       Impact factor: 2.692

4.  Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings.

Authors:  Huiping Wang; Fen Wang; Yushi Zhang; Jin Wen; Dexin Dong; Xiaoyan Chang; Hao Sun; Xiaosen Ma; Yunying Cui; Shi Chen; Lin Lu; Weidong Ren; Anli Tong; Yuxiu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

5.  Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism.

Authors:  Mitsuhiro Kometani; Takashi Yoneda; Shigehiro Karashima; Yoshiyu Takeda; Mika Tsuiki; Akihiro Yasoda; Isao Kurihara; Norio Wada; Takuyuki Katabami; Masakatsu Sone; Takamasa Ichijo; Kouichi Tamura; Yoshihiro Ogawa; Hiroki Kobayashi; Shintaro Okamura; Nobuya Inagaki; Junji Kawashima; Megumi Fujita; Kenji Oki; Yuichi Matsuda; Akiyo Tanabe; Mitsuhide Naruse
Journal:  J Endocr Soc       Date:  2022-07-26

6.  The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.

Authors:  Taweesak Wannachalee; Elaine Caoili; Kazutaka Nanba; Aya Nanba; William E Rainey; James J Shields; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

7.  Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations.

Authors:  Yoshinori Ozeki; Yukie Tanimura; Satoshi Nagai; Takuya Nomura; Mizuki Kinoshita; Kanako Shibuta; Naoki Matsuda; Shotaro Miyamoto; Yuichi Yoshida; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Kengo Kambara; Hirotaka Shibata
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.